about
Guidelines for the use and interpretation of assays for monitoring autophagyGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)The Fc receptor for IgA (FcalphaRI, CD89)Macrophages eliminate circulating tumor cells after monoclonal antibody therapyThe importance of human FcgammaRI in mediating protection to malaria.Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in miceA novel human IgA monoclonal antibody protects against tuberculosis.The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).Neutrophils as effector cells for antibody-based immunotherapy of cancer.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth.Macrophages mediate colon carcinoma cell adhesion in the rat liver after exposure to lipopolysaccharide.Neutrophils in antibody-based immunotherapy of cancer.The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.Macrophages in skin injury and repair.Immunoglobulin A: A next generation of therapeutic antibodies?Detrimental dermal wound healing: what can we learn from the oral mucosa?Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review.Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancer.Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer.Immunoglobulin A: magic bullet or Trojan horse?Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells.Granulocytes as modulators of dendritic cell function.Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy.Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining.Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces.Blocking alpha2 integrins on rat CC531s colon carcinoma cells prevents operation-induced augmentation of liver metastases outgrowth.FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI.Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells.Macrophages direct tumour histology and clinical outcome in a colon cancer model.Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors.Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy.Carcinoma origin dictates differential skewing of monocyte functionAntibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs.
P50
Q21996341-B5256C00-BB5D-447C-B0AA-0E9D10B6D5CFQ22676705-69F98A46-3E35-456D-B964-EA536E962612Q28256169-FE9AD9B6-C4BB-4EAC-90BA-AB7B0DF7F5D4Q30569758-70019AE4-CCA9-4D89-B442-5100283C22CDQ33285037-659DD3A9-6957-4814-8FC0-BD1091E296C0Q33707941-F43CF3CC-0641-425C-A3A7-E2CD80235C82Q33800841-4C05D371-9B2E-44E9-8D62-AAE0F9F7E379Q33968915-54F714F8-8486-4EAD-A102-63D0A0F042FBQ34320733-BD85855E-3EFE-46E6-BF09-EC0B16A90E11Q34499286-1C77887D-3B12-4C5F-B609-7365A2EEB5BBQ36257879-4DB428FD-4FEA-4815-A162-31B978AA7446Q36476092-88B7C3E5-8E41-4FBD-9F05-EC06DF97814BQ37032641-A0002652-94C6-4A49-8AFE-F13D5926DF10Q37456058-898ABCD8-58A5-4E5C-82F9-ED417F5C4DFAQ37833809-8AF21622-8ECC-4FC4-9723-ADD77369C60BQ37892323-838ABA0A-5715-487A-86A5-EAFA3F3D8719Q38127472-CA6EF11F-DD37-487C-8CE1-3F23E19811F2Q38151574-8D2075DF-E3A3-47F9-803E-E2C6C8425476Q38239286-3A21D506-EA74-4B08-A696-D64145F8DA67Q38634885-400E1C72-91CC-46EF-8A15-4CE60C949354Q38778020-7A71BE61-7D15-4BCA-A39B-DF150D9C9E53Q39358478-7A411D9F-D9BE-4D78-B05A-3D9E5111736FQ39392618-88EEFA6E-A640-4F34-9C6E-DDE116918319Q39528565-2C312C8E-64C3-42B7-995B-068D6E723348Q39600849-3963FBB0-5605-432B-B35D-C94858E8C93AQ40031430-A024C72E-71FF-4299-9114-01FF0D8E0091Q40031900-31A20FEF-A542-4FCF-9E83-C4FC19DEFB32Q40091318-5C216A42-41F8-4A99-91F0-3AE5CC759D7AQ40241781-9FBBE267-B14D-4124-8961-8A33FECB802AQ40384445-6409030C-F213-4497-9698-A8C3BD97371FQ40432649-ED4E9F7F-FA23-416F-A493-1C1BFBA08F9EQ40877559-834A3A9F-1FA9-4735-AF0E-FC1FD288846DQ41475462-996E2F1F-6F03-4C0B-9D05-8899BE8FCCF3Q41548146-83977301-4174-49CF-A2E0-8D2B715D03C5
P50
description
onderzoeker
@nl
name
Marjolein van Egmond
@ast
Marjolein van Egmond
@en
Marjolein van Egmond
@es
Marjolein van Egmond
@nl
Marjolein van Egmond
@sl
type
label
Marjolein van Egmond
@ast
Marjolein van Egmond
@en
Marjolein van Egmond
@es
Marjolein van Egmond
@nl
Marjolein van Egmond
@sl
altLabel
M. van Egmond
@nl
prefLabel
Marjolein van Egmond
@ast
Marjolein van Egmond
@en
Marjolein van Egmond
@es
Marjolein van Egmond
@nl
Marjolein van Egmond
@sl